MICHAEL GARZA: Open Payments
NPI 1134704158 · NIWOT, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 13 payments from 7 companies in 2025. Trend: 2023 $268 · 2024 $162 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $142 |
| ABBVIE INC. | 4 | $81 |
| Neurocrine BioSciences, Inc. | 2 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $28 |
| Lilly USA, LLC | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: CAPLYTA, VRAYLAR, INGREZZA, COBENFY, KISUNLA, Jornay PM, SPRAVATO.
Industry payments across CO — which companies pay providers there.
